KemPharm, Inc. (KMPH)
NASDAQ: KMPH · IEX Real-Time Price · USD
6.11
-0.07 (-1.13%)
Aug 12, 2022 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
|
28.65 | 13.29 | 12.84 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth (YoY)
|
115.61% | 3.50% | - | - | - | - | - | - | - |
| Gross Profit
|
28.65 | 13.29 | 12.84 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin
|
8.7 | 7.92 | 10.82 | 12.51 | 12.77 | 14 | 8.88 | 4.53 | 1.35 |
| Research & Development
|
10.16 | 8.84 | 19.42 | 41.76 | 20.59 | 20.47 | 13.93 | 11.92 | 3.37 |
| Other Operating Expenses
|
2.06 | 2.13 | 2.95 | 1.64 | 0 | 3.01 | 0 | 0 | 0 |
| Operating Expenses
|
20.92 | 18.9 | 33.18 | 55.9 | 33.37 | 37.48 | 22.81 | 16.44 | 4.72 |
| Operating Income
|
7.73 | -5.61 | -20.34 | -55.9 | -33.37 | -37.48 | -22.81 | -16.44 | -4.72 |
| Interest Expense / Income
|
0.23 | 4.79 | 4.86 | 5.47 | 5.78 | 5.51 | 2.67 | 1.61 | 0.16 |
| Other Expense / Income
|
16.02 | 2.4 | -0.65 | -4.78 | 4.29 | -26.46 | 29.15 | 6.43 | 0.37 |
| Pretax Income
|
-8.52 | -12.79 | -24.54 | -56.59 | -43.43 | -16.53 | -54.64 | -24.48 | -5.25 |
| Income Tax
|
0.03 | -0.03 | -0.02 | -0.13 | -0.04 | -0.02 | 0.03 | -0.02 | -0.02 |
| Net Income
|
-8.56 | -12.76 | -24.52 | -56.47 | -43.39 | -16.52 | -54.66 | -24.46 | -5.23 |
| Preferred Dividends
|
54.34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Common
|
-62.9 | -12.76 | -24.52 | -56.47 | -43.39 | -16.52 | -54.66 | -24.46 | -5.23 |
| Shares Outstanding (Basic)
|
30 | 4 | 2 | 1 | 1 | 1 | 0 | 0 | 0 |
| Shares Outstanding (Diluted)
|
30 | 4 | 2 | 1 | 1 | 1 | 0 | 0 | 0 |
| Shares Change
|
647.72% | 114.79% | 65.39% | 22.36% | 0.38% | 98.10% | 209.47% | - | - |
| EPS (Basic)
|
-2.11 | -3.21 | -13.23 | -50.39 | -47.36 | -18.08 | -118.72 | -164.32 | -35.20 |
| EPS (Diluted)
|
-2.11 | -3.21 | -13.23 | -50.39 | -47.36 | -18.08 | -118.72 | -164.32 | -35.20 |
| Free Cash Flow Per Share
|
0.35 | -0.49 | -12.82 | -48.39 | -36.34 | -33.34 | -44.30 | -98.90 | -29.30 |
| Gross Margin
|
100.00% | 100.00% | 100.00% | - | - | - | - | - | - |
| Operating Margin
|
27.00% | -42.20% | -158.40% | - | - | - | - | - | - |
| Profit Margin
|
-219.50% | -96.00% | -191.00% | - | - | - | - | - | - |
| Free Cash Flow Margin
|
36.10% | -14.80% | -185.10% | - | - | - | - | - | - |
| Effective Tax Rate
|
-0.40% | 0.27% | 0.09% | 0.22% | 0.10% | 0.09% | -0.05% | 0.09% | 0.38% |
| EBITDA
|
-8.04 | -7.74 | -19.38 | -50.8 | -37.32 | -10.85 | -51.88 | -22.8 | -5.02 |
| EBITDA Margin
|
-28.10% | -58.20% | -151.00% | - | - | - | - | - | - |
| Depreciation & Amortization
|
0.26 | 0.27 | 0.3 | 0.32 | 0.34 | 0.18 | 0.08 | 0.08 | 0.07 |
| EBIT
|
-8.3 | -8.01 | -19.69 | -51.12 | -37.65 | -11.02 | -51.97 | -22.87 | -5.09 |
| EBIT Margin
|
-29.00% | -60.30% | -153.30% | - | - | - | - | - | - |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).